<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730102</url>
  </required_header>
  <id_info>
    <org_study_id>SJ-817</org_study_id>
    <secondary_id>2019-2567</secondary_id>
    <secondary_id>ALF Region Skåne</secondary_id>
    <nct_id>NCT04730102</nct_id>
  </id_info>
  <brief_title>Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells</brief_title>
  <official_title>Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Slagelse Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Skane University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Slagelse Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the existence of intraluminal malignant cells and the appropriate&#xD;
      fluid volume needed to perform rectal washout during transanal total mesorectal excision&#xD;
      (taTME) for rectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients undergoing taTME for rectal cancer is included. Following the closure of the&#xD;
      rectal lumen by a purse string suture, rectal washout is performed with a total of 500 ml&#xD;
      sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline&#xD;
      after each washout. A sixth sample is collected from the presacral cavity. Each sample is&#xD;
      cytologically examined by a pathologist and labelled either malignant or non-malignant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 13, 2020</start_date>
  <completion_date type="Actual">February 9, 2021</completion_date>
  <primary_completion_date type="Actual">February 9, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Existence of intraluminal malignant cells in fluid samples from rectal washout</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Positive/negative cytology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fluid volume needed to perform rectal washout during transanal total mesorectal excision to eliminate intraluminal malignant cells</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Positive/negative cytology</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Patients undergoing rectal washout in transanal mesorectal excision</arm_group_label>
    <description>Patients undergoing rectal washout in transanal mesorectal excision for rectal cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rectal washout</intervention_name>
    <description>Rectal washout is performed intraoperatively before transection and means irrigation of the rectum following the closure of the rectal lumen below the tumour with a purse string suture. Rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity.</description>
    <arm_group_label>Patients undergoing rectal washout in transanal mesorectal excision</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing transanal mesorectal excision at Slagelse Hospital, Denmark&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Surgery at Slagelse Hospital for rectal cancer with transanal mesorectal excision&#xD;
&#xD;
          -  Consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No consent to participate&#xD;
&#xD;
          -  No surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela Buchwald</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skåne University Hospital, Malmö, Region Skåne, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Slagelse Hospital</name>
      <address>
        <city>Slagelse</city>
        <state>Zealand</state>
        <zip>4200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rectal washout</keyword>
  <keyword>transanal total mesorectal excision</keyword>
  <keyword>rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

